XML 36 R26.htm IDEA: XBRL DOCUMENT
v3.22.4

NON-CONTROLLING INTEREST | 9 Months Ended
--- | ---
Dec. 31, 2022
Non-controlling Interest |
NON-CONTROLLING INTEREST | NOTE 21. NON-CONTROLLING INTEREST
Schedule of non-controlling interest |  |  |  |  |  |  |  |  |  |  |  |
(In thousands) |  | iOx |  | Saugatuck and subsidiary |  | Total
Non-controlling interest as of April 1, 2022 |  | $ | 44,701 |  |  | $ | (472 | ) |  | $ | 44,229 |
Net income (loss) attributable to non-controlling interest |  |  | 123 |  |  |  | (171 | ) |  |  | (48 | )
Purchase of non-controlling interest pursuant to Share Exchange Agreement |  |  | (44,824 | ) |  |  | – |  |  |  | (44,824 | )
Non-controlling interest as of December 31, 2022 |  | $ | – |  |  | $ | (643 | ) |  | $ | (643 | )
(In thousands) |  | iOx |  | Saugatuck |  | Total
Non-controlling interest as of April 1, 2021 |  | $ | 46,173 |  |  | $ | (20 | ) |  | $ | 46,153 |
Share-based compensation expense |  |  | 191 |  |  |  | – |  |  |  | 191 |
Exchange of notes payable, accrued interest and warrants for iOx shares |  |  | 184 |  |  |  | – |  |  |  | 184 |
Net (loss) attributable to non-controlling interest |  |  | (436 | ) |  |  | (317 | ) |  |  | (753 | )
Non-controlling interest as of December 31, 2021 |  | $ | 46,112 |  |  | $ | (337 | ) |  | $ | 45,775 |
On September 8, 2021, the Company, through SalvaRx, completed a settlement of loans (including interest) to and receivables from iOx for services rendered in exchange for 23,772 ordinary shares of iOx at a price of £162. On July 18, 2022, the Company completed the acquisition of the remaining non-controlling interest in iOx, by issuing 1,070,000 shares of its ordinary shares and assuming certain milestone obligations. See Note 11, “Unsecured Notes Payable – iOx Unsecured Notes Payable,” and Note 18, “Related Party Transactions – Share Exchange Agreement – iOx,” for further discussions. Saugatuck and subsidiary includes Saugatuck and its wholly-owned subsidiary, Saugatuck Rx LLC.

X
- Definition The entire disclosure for interests in other entities. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2022-03-24 -Paragraph 1 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_1&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfInterestsInOtherEntitiesExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ptgef_NonControllingInterestAbstract
Namespace Prefix: | ptgef_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration